524742 Share Price Performance
₹2,024.50
122.75 (6.45%)
19.3% undervalued intrinsic discount
₹2,508.00
Fair Value
Price ₹2,024.50
AnalystConsensusTarget ₹2,508.00
Fair Value₹2,508.00
Share Price₹2,024.50
19.3% undervalued intrinsic discount
Caplin Point Laboratories Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 13 Fair Values set on narratives written by author
524742 Community Narratives
AN
Fair Value ₹2.51k 19.3% undervalued intrinsic discount
Latin American Expansion And Global Scaling Will Secure Enduring Success
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
Caplin Point Laboratories Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 74.35
- Gross Margin
- 60.75%
- Net Profit Margin
- 28.42%
- Debt/Equity Ratio
- 0.2%
Caplin Point Laboratories Limited Competitors
Snowflake Analysis
About 524742
- Founded
- 1990
- Employees
- 3966
- CEO
- WebsiteView website
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Indian Market Performance
- 7 Days: 0.6%
- 3 Months: -1.4%
- 1 Year: -4.9%
- Year to Date: 0.7%
Over the last 7 days, the market has remained flat, although notably the Information Technology sector gained 3.3% in that time. As for last year, the market is down 4.9%. Looking forward, earnings are forecast to grow by 16% annually. Market details ›